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What is Multiple Endocrine 
Neoplasia?
- Encompasses several distinct syndromes
- Tumours of the endocrine glands
- MEN1
- MEN2
- MEN3
- VHL
How do they occur? 
MEN 1 & 2 and VHL
• Autosomal dominant
• Only one mutation in one pair of genes is needed to cause the 
condition
• 50% chance of having a boy or a girl with the same condition
• Most commonly present in early adulthood and onwards
How do they occur?
MEN1 MEN2&3 VHL
Genetic screening
Can now target individuals at risk
Genetic screening allows the children from affected 
families who have NOT inherited the mutation
• Reassured
• Avoid regular clinical monitoring
• Issues re: Informed consent, counselling and confidentiality
FYI…
Von Hippel Lindau disease
Chromosome 3 – mutation in the tumour suppressor gene
Can identify the gene
• Pre-symptomatic screening
Autosomal dominant
• Each child of an affected individual has a 1 in 2 chance 
(50%) to inherit the gene alteration
Children referred
• Fellow adult endocrine teams managing in their affected 
parent
Von Hippel Lindau disease
Incidence
• 1 in 40,000
• Average age of presentation
• 26 yrs of age
Haemangioblastomas
• Brain, spinal cord, retina
Renal cysts
Phaechromocytomas
Phaeochromocytomas
Neuroendocrine tumour arising from the adrenal medulla
Usually benign, can be malignant
Excretes excess catecholamines
Uncommon cause of ­ BP \ can easily be missed
We have occasional bursts of cats when we are upset or 
stressed
• Those with phaeos have it all the time
Phaeochromocytomas
Symptoms ?
• ­BP
• Headache
• Perspiration / episodic sweating
• Palpitations
• Anxiety attacks
• May be incorrectly attributed to anxiety or depression
Can cause life threatening conditions
• Hypertensive crisis
• Mets - Stroke
• Cardiac failure - MI
Case study – VHL
Male child Tom
DOB 10.11.01
Family history of VHL
Positive for the familial mutation in exon 3 of the VHL gene
Commenced screening programme 
• 2006 age 5yrs

Clinical screening
2011
February
477nmol/day
2012
Lesion seen on abdominal 
MRI
Repeat MRI with contrast
MIBG scan
2007, 2008, 2009
All normal
2010
January
Urine catecholamine (noradrenaline) 
slightly elevated
370nmol/day (N=below 194)
Repeat and watch as asymptomatic
May
433nmol/day
June
MRI adrenal normal
October
372nmol/day
MRI Abdomen 12.10.12
Review of imaging  for endocrine VHL MDT 31.10.2012
There is a 3cm MIBG positive paraganglioma in the upper retroperitoneum
interposed between in the aorta, IVC and portal vein. No local invasion 
seen. Slow increase in size since 2008.
Small areas of soft tissue in the distal aorto-caval region but these are 
currently indeterminate.
Normal kidneys, adrenals and pancreas
Excision of paraganglioma January 2013, age 11yrs

Clinical management
April 2012
• Paraganglioma
• Small
• No plans for surgery
• Intermittent symptoms and continued raised catecholamines
• Commence Doxazocin 0.5mg once daily
• Increase to twice a day after a week if tolerated
• Continue until surgery planned
• Doxazocin
• Alpha blockade
• Reduces BP
MRI Abdomen 6.8.14
New 9mm peripherally enhancing left adrenal nodule which 
demonstrates restricted diffusion likely to represent a small 
phaechromocytoma

Clinical management
2014
• November age 13yrs
• Now wants to be seen without his Mum
• ? Phaeochromocytoma
• Tom very stressed and upset
• Psychological input offered 
2015
• Further imaging..
MRI Pancreas 23.2.15
The anterior lesion in the tail of the pancreas is still present 
and demonstrates an arterial blush
This remains suggestive of an islet cell tumour
No other pancreatic lesion is demonstrated

MRI adrenals 14.7.15
The right adrenal mass in the body of the adrenal has 
further increased in size now measures 13 mm. 
The left adrenal nodule in the lateral limb is stable 
measuring 15 mm.
Both lesions have similar properties and the appearances 
are in keeping with small phaeochromocytomas


Continued management
2015
• July
• Bilateral phaeochromocytomas
• Now proceed to surgery
• December – right adrenalectomy
2016
• April – surgical follow up
• As you know he underwent a right laparoscopic adrenalectomy for a pheochromocytoma within 
the Von Hippel Lindau syndrome in December last year, from which he made a rapid and 
uncomplicated post-operative recovery.
• On examination today, all incisions have healed well.
• We knew pre-operatively that he had bilateral phaeochromocytomas however the right was the 
largest and we hoped to proceed with a staged adrenalectomy to preserve adrenal function for 
as long as possible.  
• Unfortunately, post-operative urinary nor-metadrenaline has not decreased substantially 
although his mother tells me he remains normotensive and asymptomatic.
• I discussed the findings with him and his mother today and I have suggested that he seeks an 
early appointment with the paediatric endocrine team to discuss the potential for going back on 
to doxazosin.  He particularly would like to avoid further surgery for at least a year.  He is of 
course in his GSCE year currently.
2016
• May – paediatric endocrine (PE) follow up
• Continue here and not the family VHL clinic
• Headaches / hot flushes / diarrhoea
• August – PE follow up
• Arrangements to be made for L adrenalectomy
• Commence alpha and beta blockade
• Discussed adrenal insufficiency post op
• Dad already on HC
• September – Left adrenalectomy
• Commenced on HC 7.5 / 5 / 5 and Fludrocortisone
Bilateral adrenalectomy
• Hydrocortisone replacement
2016
• November – PE follow up
• Feeling much better
2017
• January – Cortisol day curve
• Not been feeling well, missing school mornings 
• Had had a recent viral illness 
• HC 10mg tds – felt better
• Cortisol levels low
• HC increased to 7.5mg tds
• February – Surgical follow up
• Discharged home
PE follow up imminent…
How should MEN / VHL be managed?
Screening important
Medical and surgical management
Nursing input
Liaison with adult endocrine teams
Patient support groups

• Ophthalmology review
• Fundoscopy screening
• Adrenals
• Phaeochromocytomas
• Renal carcinomas
• Now leading cause of death 
amongst VHL patients
• Successful treatment for 
CNS haemangioblastomas
• Imaging
• Genetics
• Analysis of the index case 
is key to identifying  further 
members of the family at 
risk
• Can be done from age 
5yrs
• Enable clinical screening
Reduction in morbidity 
compared to their parents
Patient support
AMEND
• UK Patient support group
• www.amend.org.uk

Conclusion
• Management of children with NETs / VHL very complex
• Importance of screening emphasised
• Genetics and clinical
• Inform families
• Reduce need for screening
• Reduction in morbidity compared to their parents
• Can screen from age 5yrs
• MEN2b genetics from age 1yr
• Shift in management
• Screening – emphasis on imaging
• Hydrocortisone management
• Patient support
• Transition
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